Vemurafenib Plus Cobimetinib Plus PEG-interferon in Advanced Melanoma Patients Harboring the V600BRAF Mutation
Clinical trial NCT01959633 · COMPLETED
Trial details
- NCT number
- NCT01959633
- Sponsor
- Fondazione Melanoma Onlus
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-03
- Primary completion
- 2018-03-26
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.